文献
J-GLOBAL ID:202102252557117114
整理番号:21A0017616
中等度から重度の重度COPD患者の肺機能改善と増悪減少におけるグリコピロラート/ホルモテロールフマル酸塩定量吸入剤(GFF MDI)の利点:PINNACLE研究のプール解析【JST・京大機械翻訳】
Benefits of glycopyrrolate/formoterol fumarate metered dose inhaler (GFF MDI) in improving lung function and reducing exacerbations in patients with moderate-to-very severe COPD: a pooled analysis of the PINNACLE studies
著者 (10件):
Martinez Fernando J.
(Weill Cornell Medical College, New York-Presbyterian Hospital/Weill Cornell Medical Center, New York, USA)
,
Lipworth Brian J.
(Scottish Centre for Respiratory Research, Ninewells Hospital, University of Dundee, Dundee, UK)
,
Rabe Klaus F.
(LungenClinic Grosshansdorf and Christian-Albrechts University Kiel, Airway Research Center North, Member of the German Center for Lung Research (DZL), Kiel, Germany)
,
Collier David J.
(William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK)
,
Ferguson Gary T.
(Pulmonary Research Institute of Southeast Michigan, Farmington Hills, USA)
,
Sethi Sanjay
(University at Buffalo, SUNY, Buffalo, USA)
,
Feldman Gregory J.
(S. Carolina Pharmaceutical Research, Spartanburg, USA)
,
O’Brien Gerald
(formerly of AstraZeneca, Wilmington, USA)
,
Jenkins Martin
(AstraZeneca, Cambridge, UK)
,
Reisner Colin
(AstraZeneca, Morristown, USA)
資料名:
Respiratory Research (Web)
(Respiratory Research (Web))
巻:
21
号:
1
ページ:
1-14
発行年:
2020年
JST資料番号:
U7545A
ISSN:
1465-993X
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
イギリス (GBR)
言語:
英語 (EN)